11-oxygenated Androgens in PCOS

Open-label trial (2 arms), sponsored by University of Birmingham. Primary endpoints: The impact of classic and 11-oxygenated androgen precursors on systemic circulation of overall steroid profile and its impact on lipid and glucose metabolism-establishing baseline height at 3 years, The impact of classic and 11-oxygenated androgen precursors on systemic circulation of overall steroid profile and its impact on lipid and glucose metabolism-establishing baseline weight at 3 years and 27 more. Status: unknown.